Skip to main content
. 2020 Aug 16;36(3):700–709. doi: 10.1111/jgh.15205

TABLE 1.

Number of consultant questions recorded in telemedicine visit during 1 month before and after COVID‐19 outbreak

COVID‐19 Smartphone message WeChat Online consultant Total
Before After Before After After Before After
Disease evaluation Related Delay of lab test 0 0 0 4 0 0 4
Delay of colonoscopy 0 1 0 6 1 0 8
Non‐related Preparation for lab test 1 0 5 2 0 6 2
Check for lab results 3 1 22 9 0 25 10
Interpreting lab results 3 0 51 25 15 54 40
Medication
IFX Related Delay of IFX infusion 0 12 0 17 3 0 32
Non‐related Make an appointment for infusion 30 39 52 57 0 82 96
Policy about reimbursement 32 34 65 24 0 97 58
Others 48 9 253 18 6 301 33
Others Related Limited access to MTX injection 0 1 0 4 2 0 7
Alternative purchase approach 0 8 0 71 37 0 116
Drug withdrawal due to outbreak 0 0 0 2 1 0 3
Non‐related Time of drug withdrawal 0 0 2 1 5 2 6
Way of using drugs 7 0 3 8 18 10 26
Adverse events 2 0 1 4 5 3 9
Disease flare Related Selective surgery 0 0 0 6 0 0 6
Non‐related Flare 6 4 26 15 40 32 59
Emergency Operation 0 0 0 2 1 0 3
Hospitalization 0 0 0 1 0 0 1
Self‐management Non‐related Diet 0 0 2 3 1 2 4
Non‐related Pregnancy/fertility 0 0 1 3 2 1 5
Hospital visit Related Opening hours of IBD clinic 0 7 0 13 2 0 22
Self‐protection during hospital visit 0 2 0 1 0 0 3
Online clinic consulting 0 0 0 5 2 0 7
Non‐related Appointment of hospitalization 7 0 8 8 0 15 8
Visiting flow 10 2 58 10 0 68 12
Respiratory symptoms Related Cough 0 1 0 0 0 0 1
Fever 1 0 4 5 3 5 8
Chest tightness 0 0 0 2 1 0 3
Rhinorrhea, sore throat 0 0 2 1 0 2 1
Travel Related Public transport 0 2 0 1 1 0 4
Self‐protection 0 1 0 4 0 0 5
Non‐related 2 0 8 3 0 10 3
Others Non‐related Insurance 6 0 27 2 1 33 3
Total 158 124 590 337 147 748 608

IFX, infliximab; MTX, methotrexate.